Latest Breaking News On - Adalimumab biosimilar market size - Page 1 : comparemela.com

Adalimumab BS for subcutaneous injection is a biosimilar of Humira, offering therapeutic solutions for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, Crohn s disease and ulcerative colitis

Japan
Japanese
Biocon-biologics
Biocon-ltd
Fujifilm-kyowa-kirin-biologics-co-ltd
Biocon-biologics-ltd
Biologics-ltd
Adalimumab-biosimilar-market-size
Biocon-biologic
Biocon
Biocon-biologics
Japan